probiotics
Industry
The non-exclusive agreement will support MRM Health’s live biotherapeutic pipeline, with commercial-scale manufacturing targeted from 2030.
Scientific research, Immunology
Stress can impair blood-forming stem cells through a brain-gut-bone marrow pathway, making them produce fewer mature immune cells.
Scientific research
Microbiota-targeted approaches that boost specific SCFAs could help prevent harmful Candida overgrowth in vulnerable people.
Humiome® B2 uses a patented coating technology intended to transport riboflavin through the upper gastrointestinal tract and release most of it in the ileal-colonic region.
Pediatrics
Boosting the gut metabolite indoleacrylic acid (IA), either directly or through the probiotic Bifidobacterium longum subsp. infantis, help protect the gut and prevent NEC.
Gynecology
Using probiotics such as LACTIN-V after antibiotic treatment could help prevent bacterial vaginosis, opening the way for tailored treatments based on individual microbiota profiles.
Industry
The agreement covers the development and future commercialization in Europe of VOWST®, the first oral LBP approved in the United States to prevent recurrent Clostridioides difficile infection.
Pediatrics
To better define the role of biotics in infant formula, future studies should be specifically designed to assess infection prevention, with adequate sample sizes, harmonised formulations and long-term follow-up.
Video, Gastroenterology
Francisco Guarner, from Centro Médico Teknon in Barcelona, discusses the role of probiotics in the prevention of antibiotic-associated diarrhea.
"Wake Up Your Core" concept presented at Vitafoods Europe 2026 recognizes the gut microbiota as the foundation of overall health and a key driver of systemic homeostasis.